Upcoming Community Forums: Click on the links below for agenda details and information on how to register.
Date/ Time | Working Group | Title | Speakers |
---|
5 October 14:00 –15:00 (BST) 09:00–10:00 (EDT). | Real World Evidence | Experiences with Adapting RWD into CDISC Submission Standards (Registration opening soon) | Lauren Green (Amgen), Jeffrey Abolafia (Pinnacle 21) Christine Rossin (Pfizer) and Sandra VanPelt Nguyen (Pfizer |
Previous Community Forum: Click on links below for more information to view the recordings.
Date/ Time | Working Group | Title | Speakers | Recordings |
---|
18 January | Emerging Trends & Technologies | Submitting Real-world Data | Parag Shiralkar (Sumptuous Data Sciences) and Jeff Abolafia (Pinnacle 21) | Recording | 16 February | Safety Analytics | Reimagining a Safety Submission – Aggregate Safety Assessment Planning | Greg Ball (ASAPprocess), Mary Nilsson (Eli Lilly), Mac Gordon (Janssen Research & Development) and Barbara Hendrickson (University of Chicago) | Recording | 21 February | Data Transparency | Data Privacy and Data Sharing in Clinical Trials | Devaki Thavarajah (Instem) and Deborah Collyar, Founder and President, Patient Advocates in Research (PAIR) | Recording | 27 March | Safety Analytics | Reimagining a Safety Submission – Vision of Interactive Safety Reviews | Greg Ball (ASAPprocess), Mary Nilsson (Eli Lilly), Wei Wang (Eli Lilly), Xiangyun Wang (Genentech), Raj Kiran (Takeda), Melvin Munsaka (Abbvie), Neetu Sangari, (Pfizer), Jeremy Wildfire (Gilead), Khushboo Sharma, (Accumulus) and Bill Gibson, (Accumulus) | Recording | 12 April | Emerging Trends & Technologies | RWD/RWE Programming & Reporting Standards: Utilising OMOP Standards | Berber Snoeijer (ClinLine), Mary Anne Rutkowski (Merck & Co), Jerry Wang (Janssen Research and Development), Mike Briganti (Janssen Research & Development) | Recording | 6 July | Real World Evidence | Designing Your RWD Study: Is Your Data Fit for Purpose? | Andy Richardson (Zenetar), Elizabeth Merrall (Janssen Research and Development), Jonathan Assayag (Pfizer) and Mary Anne Rutkowski (Merck) | Recording |
|